The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
Lauren M. Granat(Cleveland Clinic), Dong Zhang(Fudan University), Kian Parsa(New York Institute of Technology), Ooha Kambhampati(New York Institute of Technology), Brian Niedzwecki(New York Institute of Technology), Stephanie Klosek(New York Institute of Technology)
Cited by 53
Related Papers
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
|Science|2007|696
The ubiquitin-specific protease USP28 is required for MYC stability
|Nature Cell Biology|2007|491
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
|Cancers|2020|255